Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 7131-7139

  Han, Ying ^a   Xu, Guang Xu ^a   Lu, Huan ^a   Yu, Dan Hua ^b,c   Ren, Yuan ^c   Wang, Li ^a   Huang, Xu Hong ^a   Hou, Wen Jing ^a   Wei, Zhen Hong ^a   Chen, Yuan Ping ^a   Cao, Yun Gui ^d   Zhang, Rong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Nanjing Medical University   (China)

^d Shanghai Jiading Maternal and Child Health Care Hospital   (China)

Author keywords

Biomarker; Cervical cancer; miRNA 21

Indexed keywords

MICRORNA; MIRN21 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; FEMALE; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENETICS; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR INVASION; UPREGULATION; UTERINE CERVICAL NEOPLASMS;

ADULT; BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TESTING; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84938631797     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. de Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GAH, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SCB, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJLM, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N and Bosch FX. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-1056.
2. Sahiner F. Current Problems and Recent Advances in the Molecular Diagnosis of Genital Human Papillomavirus Infections. Mikrobiyol Bul 2014; 48: 689-706.
3. Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K and Aoki D. MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment. Scientific World Journal 2014; 2014: 178075.
4. Gocze KGK, Kovacs K, Juhasz K, Gocze P, Kiss I. MicroRNA Expressions in HPV-induced Cer-vical Dysplasia and Cancer. Anticancer Res 2015; 35: 523-530.
5. Buonaguro FM, Pauza D, Tornesello ML, Hainaut P, Franco R and Marincola FM. Cancer diagnostic and predictive biomarkers. Biomed Res Int 2014; 2014: 980163.
6. Wang J, Zhang KY, Liu SM and Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules 2014; 19: 1912-1938.
7. Yu J, Wang Y, Dong R, Huang X, Ding S and Qiu H. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 2012; 138: 671-674.
8. Peng RQ, Wan HY, Li HF, Liu M, Li X and Tang H. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 2012; 287: 14301-14309.
9. Ding H, Wu YL, Wang YX and Zhu FF. Characteri-zation of the MicroRNA Expression Profile of Cervical Squamous Cell Carcinoma Meta-stases. Asian Pac J Cancer Prev 2014; 15: 1675-1679.
10. Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcino ma cells. Biochem Biophys Res Commun 2009; 388: 539-542.
11. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE and Kiviat NB. Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 2011; 6: e28423.
12. Liu J, Sun H, Wang X, Yu Q, Li S, Yu X and Gong W. Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer. Int J Mol Sci 2014; 15: 758-773.
13. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P and Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 2011; 6: e21646.
14. Theelen W, Litjens RJ, Vinokurova S, Haesevoets A, Reijans M, Simons G, Smedts F, Herrington CS, Ramaekers FC, von Knebel Doeberitz M, Speel EJ and Hopman AH. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies. Hum Pathol 2013; 44: 2410-2418.
15. Villegas-Ruiz V, Juárez-Méndez S, Pérez-González OA, Arreola H, Paniagua-García L, Parra-Melquiadez M, Peralta-Rodríguez R, López-Romero R, Monroy-García A, Mantilla-Morales A, Gómez-Gutiérrez G, Román-Bassaure E, Salcedo M. Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol 2014; 7: 1389-1401.